Corbus Pharmaceuticals (United States)
- Research works
- 44 ▲ 313% vs 2013–17
- Citations
- 394 9.0 per fractional work
- Top-10% rate
- 17.9% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: Corbus Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.6×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.6×
- Immunology and Microbiology 3.7×
- Medicine 3.0×
- Psychology 2.7×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Dentistry 2.0×
- Arts and Humanities 0.8×
- Materials Science 0.7×
- Business, Management and Accounting 0.5×
- Engineering 0.5×
- Neuroscience 0.4×
- Computer Science 0.1×
Who are the top researchers at Corbus Pharmaceuticals (United States)?
Ranked on the composite score, Barbara White lead among researchers whose main affiliation is Corbus Pharmaceuticals (United States).
- 1 Barbara White United States · #132,030 worldwide 229 citations · 21 works
Which keywords describe research at Corbus Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Autoantibodies, Treatment, Cancer Risk, Interstitial Lung Disease, Dermatomyositis, Inflammatory Myopathies, Inflammation and Neuroprotection.
- Tumor Targeting
- Postmodernism
- Integrins
- Focal Adhesion Kinase
- Contemporary Fiction
- Epidemiology
- Therapeutic Alliance
- Neoliberalism
- Immunosuppressive Therapy
- Smoke Control
- Cancer
- Endocannabinoid System
- Neuroprotection
- Meta-Analysis
- Dermatomyositis
- Cancer Risk
- Treatment
- Autoantibodies
- Inflammation
- Interstitial Lung Disease
- Inflammatory Myopathies
- Neurological Disorders
- Cannabinoid Receptors
- Angiogenesis
- Fibrosis
- Tunnel Fires
- Immunotherapy
- Psychotherapy Outcome
- Cell Adhesion
- Bacterial Therapy
- Epithelial-Mesenchymal Transition
- History
- Neuroscience
- Social Sciences
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Autoantibodies4▲ 39×4 topics
- Treatment4▲ 6.5×7 topics
- Inflammation3▲ 3.1×9 topics
- Cancer Risk3▲ 24×3 topics
- Interstitial Lung Disease3▲ 109×2 topics
- Dermatomyositis2▲ 347×1 topic
- Inflammatory Myopathies2▲ 347×1 topic
- Meta-Analysis2▲ 8.3×2 topics
- Neurological Disorders2▲ 6.6×2 topics
- Neuroprotection2▲ 12×2 topics
- Cannabinoid Receptors2▲ 151×1 topic
- Endocannabinoid System2▲ 151×1 topic
- Angiogenesis2▲ 9.5×3 topics
- Cancer2▲ 2.5×5 topics
- Fibrosis2▲ 18×3 topics
- Smoke Control2▲ 150×1 topic
- Tunnel Fires2▲ 150×1 topic
- Immunosuppressive Therapy1▲ 16×2 topics
- Immunotherapy1▲ 4.7×2 topics
- Neoliberalism1▲ 8.4×3 topics
- Psychotherapy Outcome1▲ 73×1 topic
- Therapeutic Alliance1▲ 73×1 topic
- Cell Adhesion1▲ 30×2 topics
- Epidemiology1▼ 0.62×6 topics
- Bacterial Therapy1▲ 52×1 topic
- Contemporary Fiction1▲ 233×1 topic
- Epithelial-Mesenchymal Transition1▲ 28×2 topics
- Focal Adhesion Kinase1▲ 40×1 topic
- History1▲ 2.9×2 topics
- Integrins1▲ 40×1 topic
- Neuroscience1▲ 7.2×2 topics
- Postmodernism1▲ 53×1 topic
- Social Sciences1▲ 14×2 topics
- Tumor Targeting1▲ 17×1 topic
Which research topics does Corbus Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Cancer Research and Treatments, Inflammatory Myopathies and Dermatomyositis, Cannabis and Cannabinoid Research and Cell Adhesion Molecules Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 1 works
- 2 Inflammatory Myopathies and Dermatomyositis Epidemiology 1 works
- 3 Cannabis and Cannabinoid Research Pharmacology 1 works
- 4 Cell Adhesion Molecules Research Immunology and Allergy 1 works
- 5 Cancer Cells and Metastasis Oncology 1 works
- 6 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
- 7 Pharmacology and Obesity Treatment Pharmacology 0 works
- 8 Galectins and Cancer Biology Immunology 0 works
- 9 Bipolar Disorder and Treatment Psychiatry and Mental health 0 works
- 10 Urinary and Genital Oncology Studies Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Corbus Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 313% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Norwood
- Analog Devices (United States)
- EIC Laboratories
- Norwood Hospital
- Apogee Technology (United States)
- Innovative Chemical and Environmental Technologies (United States)
- Spectra Solutions (United States)
- 1Globe Health Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.